Contrasting Flag Ship Acquisition (ETHZ) & Its Peers

Flag Ship Acquisition (NASDAQ:ETHZ) is one of 9,618 publicly-traded companies in the “” industry, but how does it contrast to its rivals? We will compare Flag Ship Acquisition to related businesses based on the strength of its profitability, risk, analyst recommendations, dividends, institutional ownership, valuation and earnings.

Risk and Volatility

Flag Ship Acquisition has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, Flag Ship Acquisition’s rivals have a beta of 0.73, meaning that their average stock price is 27% less volatile than the S&P 500.

Earnings and Valuation

This table compares Flag Ship Acquisition and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Flag Ship Acquisition	N/A	-$6.17 million	-0.12
Flag Ship Acquisition Competitors	$5.65 billion	$73.99 million	-505.68

Flag Ship Acquisition’s rivals have higher revenue and earnings than Flag Ship Acquisition. Flag Ship Acquisition is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Flag Ship Acquisition and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Flag Ship Acquisition	N/A	-141.25%	-80.77%
Flag Ship Acquisition Competitors	-1,521.64%	-68.48%	-11.04%

Insider and Institutional Ownership

4.1% of Flag Ship Acquisition shares are held by institutional investors. Comparatively, 50.0% of shares of all “” companies are held by institutional investors. 5.4% of Flag Ship Acquisition shares are held by company insiders. Comparatively, 15.2% of shares of all “” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Flag Ship Acquisition and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flag Ship Acquisition	1	0	0	0	1.00
Flag Ship Acquisition Competitors	4261	23126	28787	779	2.46

As a group, “” companies have a potential upside of 35.89%. Given Flag Ship Acquisition’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Flag Ship Acquisition has less favorable growth aspects than its rivals.

Summary

Flag Ship Acquisition rivals beat Flag Ship Acquisition on 11 of the 13 factors compared.

About Flag Ship Acquisition

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.